LncRNA RARA-AS1 could serve as a novel prognostic biomarker in pan-cancer and promote proliferation and migration in glioblastoma

Long non-coding RNAs (lncRNAs) have emerged as crucial regulators of cancer progression and are potential biomarkers for diagnosis and treatment. This study investigates the role of RARA Antisense RNA 1 (RARA-AS1) in cancer and its implications for diagnosis and treatment. Various bioinformatics too...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yue, Deng, Song, Jiang, Qiaoji, Shi, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575974/
https://www.ncbi.nlm.nih.gov/pubmed/37833349
http://dx.doi.org/10.1038/s41598-023-44677-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575974/
https://www.ncbi.nlm.nih.gov/pubmed/37833349
http://dx.doi.org/10.1038/s41598-023-44677-4

Ejemplares similares